Betaine Inhibits NLRP3 Inflammasome Hyperactivation and Regulates Microglial M1/M2 Phenotypic Differentiation, Thereby Attenuating Lipopolysaccharide-Induced Depression-Like Behavior

• Published in: Journal of Immunology Research Vol. 2022; pp. 1 - 14
• Main Authors: Zhang, Man, Wang, Xiao-Long, Shi, Hui, Meng, Lan-Qing, Quan, Hong-Feng, Yan, Lin, Yang, Hui-Fang, Peng, Xiao-Dong
• Format: Journal Article
• Language: English
• Published: New York Hindawi 26.10.2022; John Wiley & Sons, Inc; Hindawi Limited; Wiley
• Subjects: Animals; Antidepressants; Behavior; Betaine; Brain; Caspase-1; Cytokines; Depression, Mental; Drinking water; Enzyme-linked immunosorbent assay; Food; Genotype & phenotype; Herbal medicine; Hypotheses; IL-1β; Immunofluorescence; Immunohistochemistry; Immunology; Inflammasomes; Inflammation; Lipopolysaccharides; Mental depression; Mental disorders; Microglia; Morphology; Natural products; Nervous system; Neuroprotection; Nitric oxide; Nitric-oxide synthase; Oligomerization; Open-field behavior; Phenotypes; Polarization; Protein binding; Sucrose; Tetracycline; Tetracyclines; Tumor necrosis factor-TNF; Tumor necrosis factor-α; Western blotting; China
• ISSN: 2314-8861; 2314-7156
• DOI: 10.1155/2022/9313436

Depression is one of the most important mental illnesses and is closely related to inflammation. Betaine is a natural product with an anti-inflammatory and antioxidant activities. However, the mechanism by which betaine ameliorates depression-like behaviors induced by lipopolysaccharide (LPS) is poorly understood. The purpose of this study was to investigate the neuroprotective effect of betaine on LPS-induced depression-like behavior in mice and its mechanism of action. ICR mice were randomly divided into four groups: the control group, the LPS model group (0.83 mg/kg), the positive drug group (MIDO, 50 mg/kg), and the betaine group (5% and 1% in drinking water). The betaine group was administered for 21 days, and on the 22nd day, except for the blank group, LPS (0.83 mg/kg) was intraperitoneally injected to establish a lipopolysaccharide-induced mice depression-like model. Twenty-four hours after LPS injection, the tail suspension test (TST), open field test (OFT), and sucrose preference test (SPT) were performed to evaluate the effect of betaine on LPS-induced depressive behavior in mice. After the behavioral study, the mouse brain, hippocampus, and serum were taken for detection. The expressions of cytokines and inflammatory mediators were detected by ELISA, HE staining, immunofluorescence, immunohistochemistry, and western blotting. Western blotting was used to detect the protein expression levels of the nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3), caspase-1, and ASC, the protein expression levels of the microglial polarization markers COX-2, inducible nitric oxide synthase (iNOS), and CD206. The results showed that betaine significantly ameliorated the depression-like behavior in LPS-induced mice, significantly attenuated the production of proinflammatory cytokines and increased the release of an anti-inflammatory cytokines. Betaine decreased the expression of the NLRP3 inflammasome, decreased the expression of M1 polarization markers, tumor necrosis factor-alpha (TNF-α), interleukin-1β (IL-1β), COX-2, and iNOS and promoted the expression of M2 polarization marker CD206. Our study suggests that betaine may promote the transition of microglia from the M1 to the M2 phenotype by inhibiting NLRP3 inflammasome activation, thereby attenuating lipopolysaccharide-induced depression-like behavior.